Addition of Acalabrutinib to Lenalidomide and Rituximab Induces High Complete Response Rates in Patients with Previously Untreated Follicular Lymphoma: Results of a Phase II StudyPaolo Strati, Lei Feng,Jason Westin,Ranjit Nair,Luis Fayad,Maria Alma Rodriguez,Dai Chihara,Luis Malpica,Jared Henderson,Mariana Gallardo,Mario L. Marques-Piubelli, Polina Turova,Aleksandr Zaitsev, Iris Wang,Christopher R. Flowers,Loretta J. Nastoupil,Sattva S. NeelapuBlood（2023）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
